SABS   $0.85  -4.92% Market Closed

SAB Biotherapeutics Inc
Total Cash 37.33M
totalCashPerShare 4.044
EBITDA -40.91M
Total Debt 5.34M
quickRatio 4.972
currentRatio 5.241
Total Revenue 2.78M
debtToEquity 11.584
Revenue/Share 0.365
ROA -0.58804
ROE -1.22487
grossProfits
freeCashflow -26.69M
operatingCashflow -37.08M
earningsGrowth
revenueGrowth 2.077
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins -38.769527
profitMargins 0.0
enterpriseValue 4.47M
forwardPE -1.4311595
floatShares 5.99M
sharesOutstanding 9.23M
sharesShort 79.82K
sharesShortPriorMonth 30.23K
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.19%
heldPercentInstitutions 0.35%
Short Ratio help_outline 1.53%
shortPercentOfFloat 0.01%
impliedSharesOutstanding
bookValue 4.997
Price To Book help_outline 0.79
earningsQuarterlyGrowth
netIncomeToCommon -40.32M
trailingEps -5.82%
forwardEps -2.76%
enterpriseToEbitda -0.11
lastDividendValue
lastDividendDate
currentQuarterEstimate -1.09 3Q 2024
institutionsCount 26
lastUpdated Nov. 7, 2024, 6:58 a.m.